Join to View Full Profile
400 South Clark StButte, MT 59701
Phone+1 406-723-2500
Fax+1 903-213-9092
Dr. Gilroy is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jeffrey Gilroy, MD, is a Radiation Oncologist based in Butte, MT. He completed his medical education at the University of Nebraska College of Medicine and his residency in Radiation Oncology at the University of Florida. His experience includes a focus on stereotactic and functional surgery, general radiation oncology, and intensity-modulated radiation therapy. Previously, he served as Medical Director at Anova Cancer Care from 2017 to 2020. Dr. Gilroy has contributed to several research publications, particularly in the areas of breast-conserving therapy and head and neck cancer prognosis. He received the CMS Meaningful Use Stage 1 Certification from MOSAIQ EMR, Elekta in 2014.
Education & Training
University of FloridaResidency, Radiation Oncology, 2000 - 2004
Creighton University School of Medicine (Omaha)Internship, Internal Medicine, 1999 - 2000
University of Nebraska College of MedicineClass of 1999, MD
Texas Christian UniversityBS, biology, 1991 - 1995
Certifications & Licensure
MT State Medical License 2020 - 2028
CO State Medical License 2010 - 2027
WY State Medical License 2012 - 2027
NE State Medical License 2021 - 2026
TX State Medical License 2014 - 2026
ID State Medical License 2020 - 2023
MN State Medical License 2021 - 2023
American Board of Radiology Radiation Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2014
Publications & Presentations
PubMed
- 59 citationsMinimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance.E. Ramsay Camp, Priscilla F. McAuliffe, Jeffrey S. Gilroy, Christopher G. Morris, D. Scott Lind
Journal of the American College of Surgeons. 2005-12-01 - 2 citationsBreast-conserving therapy in patients with bilateral breast cancer: Do today’s treatment choices burn bridges for tomorrow?Jeffrey S. Gilroy, Christopher G. Morris, Nancy P. Mendenhall
International Journal of Radiation Oncology, Biology, Physics. 2005-06-01 - 31 citationsImpact of young age on prognosis for head and neck cancer: a matched-pair analysis.Jeffrey S. Gilroy, Christopher G. Morris, Robert J. Amdur, William M. Mendenhall
Head & Neck. 2005-04-01
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
